Learn how to obtain non-dilutive funding from and build relationships with the DoD! Are you looking for opportunities to showcase your medical innovations and capabilities to the military, and gain understanding of government funding priorities – but not sure where to start?   Join us to learn about: How to maximize participation in the 2024…

BUILDING CONNECTIONS, BREAKING BARRIERS When the stakes are this high, we can’t go it alone. BIO unites a global network of business leaders, policymakers, investors and scientists for a common purpose: curing patients, protecting the planet, and nourishing humanity. Gain inspiration and critical insights from global thought leaders addressing critical topics at the intersection of…

Don’t miss your chance to hear directly from the Small Business Lead at the NIH’s, National Heart, Lung, and Blood Institute )NHLBI), Dr. Stephanie Davis. The NHLBI plans, conducts and supports research, clinical trials and demonstration and education projects related to the causes, prevention, diagnosis and treatment of heart, blood vessel, lung, and blood diseases…

Join Dr. Andrea Johanson, Sr. Principal Consultant with the BBCetc, as she clarifies the mission and goals of the National Institute of Health (NIH), National Science Foundation (NSF) and Department of Defense (DOD) SBIR/STTR Programs. The Session will provide a concise overview of three major agencies, their funding priorities and application processes, alongside guidance on…

Registration is now open for AdvaMed’s MedTech Coverage, Coding and Reimbursement 101 Workshop! This 101 Workshop will discuss the “three-legged stool” of payment—coding, coverage, and reimbursement—as well as reviewing market access opportunities for novel technologies through both existing Medicare payment pathways and proposals to streamline Medicare policies in the future.  

Register today for MDMA’s flagship event, the 2024 MDMA Annual Meeting. MDMA is the leading voice for innovative and entrepreneurial medical devices companies, and this year’s Annual Meeting will deliver key insights on issues facing our industry. Attendees at this year’s conference will hear from Congressional, Federal Agency and industry leaders on current and upcoming issues…

Hear from federal government officials about the regulatory environment for plant, animal, and microbial biotech Learn from members of Congress about intellectual property protection, international trade and policy affecting the bioeconomy Discuss important innovations and challenges facing the industry Network with other leaders in the space around climate and sustainability action Get involved with BIO’s…

We’re pleased to invite you to the FDA/AdvaMed Medical Device Statistical Issues (MDSI) Conference in Washington, D.C., on April 2-3, 2024. This distinctive conference stands alone as the only gathering dedicated solely to in-depth discussions on statistical aspects within the field of medical devices. Panelists will share insights on the recent and future developments of statistical…

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and…

SAVE THE DATE! MDMA’s 2024 FDA Forum March 13-14, 2024 Palo Alto, CA Registration is Open! MDMA Members $695 – NonMembers $895 Agenda Available Soon! *Attendees receive up to 6 credits towards RAC re-certification upon completion